혈액형 검사 시장 규모, 점유율, 성장 분석 : 제품 유형별, 검사 유형별, 기술별, 기술별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Blood Group Typing Market size was valued at USD 2.06 Billion in 2024 and is poised to grow from USD 2.25 Billion in 2025 to USD 4.52 Billion by 2033, growing at a CAGR of 9.1% during the forecast period (2026-2033).

The global blood group typing market is witnessing significant growth due to various factors, including technological advancements and increasing healthcare access. The prevalence of chronic diseases that necessitate blood transfusions, along with a rising demand for organ transplants, is driving market expansion. Innovations such as PCR-based methods, microarray technologies, and massively parallel sequencing have markedly improved blood typing accuracy and efficiency. Additionally, the rapid proliferation of hospitals, clinics, and diagnostic centers globally enhances the demand for these services. The integration of AI and automation in blood typing processes further boosts diagnostic speed and precision. However, challenges such as high costs, inadequate infrastructure, and ethical considerations could hinder market penetration in various regions. Overall, the outlook for blood group typing remains robust.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Group Typing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Group Typing Market Segments Analysis

Global Blood Group Typing Market is segmented by Product, Test Type, Technique, Technology, Application, End User and region. Based on Product, the market is segmented into Consumables, Instruments and Services & Software. Based on Test Type, the market is segmented into ABO Blood Tests & Rh Typing, Antibody Screening, HLA Typing, Cross-matching Tests and Antigen Typing. Based on Technique, the market is segmented into Assay-based Techniques, PCR-based and Microarray Techniques, Massively Parallel Sequencing and Other Techniques. Based on Technology, the market is segmented into Molecular Typing, Serological Typing, Microarray-based Typing and Next-generation Sequencing. Based on Application, the market is segmented into Blood transfusions, Organ transplants and Diagnostic testing. Based on End User, the market is segmented into Hospitals, Blood Banks, Clinical Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Group Typing Market

The Global Blood Group Typing market is experiencing growth driven by various government initiatives aimed at promoting blood donation and enhancing the safety of blood transfusions. These measures play a crucial role in raising awareness and improving access to blood typing services, thereby positively influencing market prospects. Additionally, public health campaigns and financial support for blood typing equipment are encouraging healthcare facilities to adopt cutting-edge technologies in blood typing. As these initiatives progress, they create a more conducive environment for advancements in blood group typing, ultimately benefiting the overall healthcare sector and ensuring the availability of safe transfusion practices.

Restraints in the Global Blood Group Typing Market

The Global Blood Group Typing market faces notable challenges due to inconsistencies in test results and difficulties in maintaining accurate outcomes. Variations in testing methods, the quality of reagents, and the skill levels of operators contribute to this lack of reliability. Such inconsistencies can pose risks to patient safety and undermine the credibility of blood typing processes. Consequently, these challenges may impede the wider acceptance and integration of blood group typing solutions and services, potentially limiting advancements in this sector. Addressing these issues is crucial for ensuring the efficacy and trustworthiness of blood group typing practices.

Market Trends of the Global Blood Group Typing Market

The Global Blood Group Typing market is experiencing a significant shift towards the adoption of advanced molecular blood typing techniques, moving away from traditional serological methods. This trend is driven by the increasing demand for precision in identifying rare and weak blood group antigens, which is crucial for complex cases like prenatal testing and patients requiring multiple transfusions. Molecular methods, including PCR and DNA sequencing, enhance accuracy while simultaneously minimizing the risks of alloimmunization and transfusion reactions. As healthcare providers recognize the benefits of these innovative technologies, the blood group typing industry is poised for revenue growth, responding to the evolving needs of patients and medical professionals alike.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Startup Analysis
• Raw Material Analysis

Global Blood Group Typing Market Size by Product & Service & CAGR (2026-2033)

• Market Overview
• Consumables
  • Antisera Reagents
  • Anti-human Globulin Reagents
  • Red Blood Cell Reagents
  • Blood Bank Saline
• Instruments
• Services & Software

Global Blood Group Typing Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• ABO Blood Tests & Rh Typing
• Antibody Screening
• HLA Typing
• Cross-matching Tests
• Antigen Typing

Global Blood Group Typing Market Size by Technique & CAGR (2026-2033)

• Market Overview
• Assay-based Techniques
• PCR-based and Microarray Techniques
• Massively Parallel Sequencing
• Other Techniques

Global Blood Group Typing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Molecular Typing
• Serological Typing
• Microarray-based Typing
• Next-generation Sequencing

Global Blood Group Typing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Blood transfusions
• Organ transplants
• Diagnostic testing

Global Blood Group Typing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Blood Banks
• Clinical Laboratories
• Other End Users

Global Blood Group Typing Market Size & CAGR (2026-2033)

• North America (Product & Service, Test Type, Technique, Technology, Application, End User)
  • US
  • Canada
• Europe (Product & Service, Test Type, Technique, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Test Type, Technique, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Test Type, Technique, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Test Type, Technique, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quotient Limited (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIAGAST (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tulip Diagnostics (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AXO Science (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MTC Invitro Diagnostics (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BAG Diagnostics GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Labs Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NG Biotech (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Demeditec Diagnostics GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sero AS (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcor Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tulip Group (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medion Grifols Diagnostics AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations